G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,409 | +8.3% | 105,385 | +136.3% | 0.01% | -23.1% |
| Q4 2022 | $242,194 | -50.9% | 44,603 | +12.9% | 0.01% | -31.6% |
| Q3 2022 | $493,000 | +142.9% | 39,500 | -3.8% | 0.02% | +111.1% |
| Q2 2022 | $203,000 | +2.5% | 41,054 | +111.6% | 0.01% | -25.0% |
| Q4 2021 | $198,000 | -73.4% | 19,400 | -42.8% | 0.01% | -83.3% |
| Q2 2021 | $744,000 | +107.2% | 33,902 | +8.9% | 0.07% | 0.0% |
| Q3 2020 | $359,000 | – | 31,124 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |